Abby E Rudolph1, Omar Martinez2, Robin Davison2, Chineye Brenda Amuchi3. 1. Department of Epidemiology and Biostatistics, Temple University College of Public Health, Philadelphia, USA. 2. School of Social Work, Temple University College of Public Health, Philadelphia, USA. 3. Department of Epidemiology, Boston University School of Public Health, Boston, USA.
Abstract
INTRODUCTION: Phylogenetic analyses can provide insights on HIV tansmission dynamics. Country and state-level differences in HIV criminalization and disclosure laws and advances in next generation sequencing could impact perceived study risks. METHODS: We present study opt-out rates and the reasons provided during enrollment for a study conducted in Boston (6/2017-8/2018). RESULTS: Of 90 patients approached to participate, 45 did not consent to participate. Reasons for not participating included unwillingness to discuss their HIV status, privacy and confidentiality concerns, disinterest, and lack of time. CONLUSIONS: Given low participation rates and concerns related to HIV disclosure, privacy, and confidentiality, these questions remain (1) should informed consent be required for all phylogenetic analyses, including deidentified and surveillance data? (2) what additional steps can researchers take to protect the privacy of individuals, particularly in contexts where HIV is criminalized or there have been civil/criminal cases investigating HIV transmission? And (3) what role can community members play to minimize the potential risks, particularly for those most marginalized? These questions require input from both researchers and community members living with HIV/AIDS.
INTRODUCTION: Phylogenetic analyses can provide insights on HIV tansmission dynamics. Country and state-level differences in HIV criminalization and disclosure laws and advances in next generation sequencing could impact perceived study risks. METHODS: We present study opt-out rates and the reasons provided during enrollment for a study conducted in Boston (6/2017-8/2018). RESULTS: Of 90 patients approached to participate, 45 did not consent to participate. Reasons for not participating included unwillingness to discuss their HIV status, privacy and confidentiality concerns, disinterest, and lack of time. CONLUSIONS: Given low participation rates and concerns related to HIV disclosure, privacy, and confidentiality, these questions remain (1) should informed consent be required for all phylogenetic analyses, including deidentified and surveillance data? (2) what additional steps can researchers take to protect the privacy of individuals, particularly in contexts where HIV is criminalized or there have been civil/criminal cases investigating HIV transmission? And (3) what role can community members play to minimize the potential risks, particularly for those most marginalized? These questions require input from both researchers and community members living with HIV/AIDS.
Entities:
Keywords:
Disclosure; HIV epidemiology; Informed consent; Phylogeny; Stigma
Authors: Philip A Chan; Shahzeb Kazi; Amaad Rana; Ilyse Blazar; Colette C Dejong; Kenneth H Mayer; Thomas K Huard; Kim Carleton; Fizza Gillani; Nicole Alexander; Zoanne Parillo; Timothy P Flanigan; Rami Kantor Journal: AIDS Res Hum Retroviruses Date: 2012-07-25 Impact factor: 2.205
Authors: Zita Lazzarini; Carol L Galletly; Eric Mykhalovskiy; Dini Harsono; Elaine O'Keefe; Merrill Singer; Robert J Levine Journal: Am J Public Health Date: 2013-06-13 Impact factor: 9.308
Authors: Martin Fisher; David Pao; Alison E Brown; Darshan Sudarshi; O Noel Gill; Patricia Cane; Andrew J Buckton; John V Parry; Anne M Johnson; Caroline Sabin; Deenan Pillay Journal: AIDS Date: 2010-07-17 Impact factor: 4.177
Authors: Anne M Audelin; Susan A Cowan; Niels Obel; Claus Nielsen; Louise B Jørgensen; Jan Gerstoft Journal: J Acquir Immune Defic Syndr Date: 2013-01-01 Impact factor: 3.731
Authors: Leslie E Wolf; Lauren A Dame; Mayank J Patel; Brett A Williams; Jefferey A Austin; Laura M Beskow Journal: J Empir Res Hum Res Ethics Date: 2012-10 Impact factor: 1.742
Authors: Sanjay R Mehta; Joel O Wertheim; Kimberly C Brouwer; Karla D Wagner; Antoine Chaillon; Steffanie Strathdee; Thomas L Patterson; Maria G Rangel; Mlenka Vargas; Ben Murrell; Richard Garfein; Susan J Little; Davey M Smith Journal: EBioMedicine Date: 2015-07-18 Impact factor: 8.143
Authors: Mary K Grabowski; Justin Lessler; Andrew D Redd; Joseph Kagaayi; Oliver Laeyendecker; Anthony Ndyanabo; Martha I Nelson; Derek A T Cummings; John Baptiste Bwanika; Amy C Mueller; Steven J Reynolds; Supriya Munshaw; Stuart C Ray; Tom Lutalo; Jordyn Manucci; Aaron A R Tobian; Larry W Chang; Chris Beyrer; Jacky M Jennings; Fred Nalugoda; David Serwadda; Maria J Wawer; Thomas C Quinn; Ronald H Gray Journal: PLoS Med Date: 2014-03-04 Impact factor: 11.069